IRIS
AMATO, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.495
AS - Asia 2.795
NA - Nord America 2.308
SA - Sud America 458
AF - Africa 77
OC - Oceania 6
Totale 9.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.194
SG - Singapore 1.503
IT - Italia 1.476
RU - Federazione Russa 1.181
CN - Cina 623
BR - Brasile 392
VN - Vietnam 278
HK - Hong Kong 200
FR - Francia 146
DE - Germania 137
NL - Olanda 135
FI - Finlandia 88
GB - Regno Unito 87
IE - Irlanda 57
CA - Canada 56
IN - India 42
MX - Messico 40
AR - Argentina 32
CI - Costa d'Avorio 29
PL - Polonia 26
BD - Bangladesh 24
AT - Austria 23
KR - Corea 22
SE - Svezia 21
ZA - Sudafrica 20
ES - Italia 19
JP - Giappone 18
HU - Ungheria 16
UA - Ucraina 16
LT - Lituania 15
IQ - Iraq 14
ID - Indonesia 12
TR - Turchia 12
CO - Colombia 11
EC - Ecuador 11
BE - Belgio 7
MA - Marocco 7
MT - Malta 7
CZ - Repubblica Ceca 6
IL - Israele 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DK - Danimarca 5
PK - Pakistan 5
VE - Venezuela 5
LU - Lussemburgo 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
EG - Egitto 3
GR - Grecia 3
LY - Libia 3
MK - Macedonia 3
NP - Nepal 3
PY - Paraguay 3
UZ - Uzbekistan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CM - Camerun 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
Totale 9.132
Salva come PNG Salva come JPEG
Città #
Singapore 702
Moscow 279
Chandler 266
Ashburn 231
Naples 210
Napoli 210
Beijing 208
Hong Kong 197
Santa Clara 117
Amsterdam 107
Hefei 104
Dong Ket 74
Los Angeles 73
Ho Chi Minh City 64
Millbury 64
Boston 52
Milan 50
Munich 48
Rome 48
Des Moines 46
Hanoi 44
Princeton 44
São Paulo 44
New York 42
Nanjing 39
Buffalo 33
Redondo Beach 32
Lawrence 29
Turku 24
Dallas 22
Brooklyn 21
Houston 21
Seattle 21
Ottawa 20
Seoul 20
Tampa 20
The Dalles 20
Warsaw 20
Wilmington 20
Chicago 19
Mexico City 19
Montreal 19
Nuremberg 19
Atlanta 18
Denver 18
Tokyo 17
Helsinki 16
Ottaviano 16
Stockholm 16
Ercolano 15
Manchester 15
Orem 15
Phoenix 14
Poplar 14
Bologna 13
London 13
Abbiategrasso 12
Boardman 11
Formia 11
Frankfurt am Main 11
Lappeenranta 11
Washington 11
Da Nang 10
Johannesburg 10
Nanchang 10
Redwood City 10
Rio de Janeiro 10
Brasília 9
Chennai 9
Hebei 9
Jiaxing 9
Vienna 9
Afragola 8
Budapest 8
Hangzhou 8
Hải Dương 8
Marsala 8
Nocera Inferiore 8
Palermo 8
Pavia 8
San Francisco 8
Shenyang 8
Baghdad 7
Biên Hòa 7
Charlotte 7
Dhaka 7
Falkenstein 7
Ferrara 7
Guangzhou 7
Melita 7
Melito Di Napoli 7
Mumbai 7
Ninh Bình 7
Norwalk 7
Querétaro 7
Salvador 7
Tianjin 7
Ankara 6
Bari 6
Belo Horizonte 6
Totale 4.327
Salva come PNG Salva come JPEG
Nome #
Analisi qualitativa e quantitativa di splicing alternativi mediante una singola reazione di droplet digital PCR 446
MicroRNA come target terapeutici per il trattamento della fibrosi cistica 221
CFTR expression during cellular senescence 173
3D Chitosan-Gallic Acid Complexes: Assessment of the Chemical and Biological Properties 166
Enhanced frequency of CFTR gene variants in couples who are candidates for assisted reproductive technology treatment. 164
Economical, legal and ethical considerations on reevaluation and retesting in molecular diagnostics 163
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 161
Clinical implication of cellular senescence on CFTR expression. 157
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. [*Coretti L. corresponding author] 156
Olfactory performance in Cystic Fibrosis patients 144
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 137
Epigenetica, diagnostica e terapia della fibrosi cistica 133
Cystic Fibrosis: The Sense of Smell 130
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 129
Cystic Fibrosis: the sense of smell. 126
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 125
Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims 124
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 124
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 124
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 123
Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults 121
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR 119
Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression 118
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization 117
A Novel DHPLC-Based Procedure for the Analysis of COL1A1 and COL1A2 Mutations in Osteogenesis Imperfecta. 116
CONVERSIONE GENICA FRA I GENI CODIFICANTI IL TRIPSINOGENO PRSS1 E PRSS2: UN EVENTO RICOMBINANTE RARO IN DUE PAZIENTI PEDIATRICI. 116
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 115
Letter to the Editor: Is there an Indication for Testing the Methylenetetrahydrofolate reductase A1298C Variant in Routine Clinical Settings? 115
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 114
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells 113
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 113
Valutazione degli effetti del butirrato sulla fisiologia intestinale mediante real-time PCR. 110
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 107
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium 106
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 105
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 105
Extensive molecular analysis of patients bearing CFTR-related disorders. 105
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 105
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: Implications for recurrence risk and prenatal diagnosis. 104
Qualitative and quantitative evaluation of alternative splicing products using the digital droplet PCR 104
The implication of MBL deficient haplotypes in acute coronary syndrome. 103
Target Protector PNA: a new tool in Cystic Fibrosis treatment 103
Two cases of microvillous inclusion disease caused by novel mutations in MYO5B gene 102
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 101
Analisi molecolare della nuova variante allelica T4Gnella regione 4G/5G del promotore del gene PAI-1. 100
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 100
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 99
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel 98
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 98
Epigenetic effects of butyrate in children with congenital chloride diarrhea: an in-vivo and in-vitro study. 96
An Update on Laboratory Diagnosis of Liver Inherited Diseases 96
Genetic Diseases That Predispose to Early Liver Cirrhosis 95
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 94
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. 94
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 94
Prothrombotic gene variants in acute myocardial infarction at a young age (yAMI). Rationale for tailored prevention strategies in specific risk-group subjects for acute coronary disease? 93
The role of functional studies in the diagnosis and treatment of Cystic Fibrosis: comparing the case of the G970D and G970R mutation. 93
Molecular analysis of prothrombotic gene variants in patients with acute ischemic stroke and with transient ischemic attack 92
GENOTYPE PREDICTS THE RESPONSE TO THERAPY IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA. 89
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 87
Identificazionee caratterizzazione di mutazioni in regioni regolatorie del gene malattia della fibrosi cistica 87
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy 86
Haemophilia A: the consequences of de novo mutations. Two case reports 85
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 85
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients. 84
Cystic fibrosis, molecular genetics for all life 83
BUTYRATE MODULATES EPITHELIAL DRA EXPRESSION IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA 82
Sars-cov-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of sars-cov-2 variants 82
Ricerca di fattori trascrizionali allele specifici per due nuove varianti riscontrate nelle CSTs di CFTR. 81
The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases 79
Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? 78
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor? 76
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 74
Patient-derived cell models for personalized medicine approaches in cystic fibrosis 73
Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 73
Lung microbiome in cystic fibrosis 68
The friendly use of chloroquine in the COVID-19 disease: A warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene 66
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in three subjects with the cystic fibrosis genotype phe508del/unknown and advanced lung disease 63
Molecular and Functional Analysis of the Large 5' Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders. 60
Congenital diarrheal disorders: an updated diagnostic approach 59
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response. 58
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype 53
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea 52
Porphyromonas somerae in urinary microbiome and its potential metabolic role in bladder cancer 51
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 50
The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control 50
Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells 39
Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator-related disorders (congenital bilateral absence of vas deferens) 39
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 36
Mouse intestine as a useful model for CFTR electrophysiology function analysis 16
null 12
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 8
Mechanisms of action of butyrate in congenital chloride diarrhea (CLD) 3
Totale 9.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 28 16 40 21 35 27 95
2021/2022694 51 25 14 25 7 32 13 37 93 109 124 164
2022/2023775 75 52 30 65 75 74 39 68 103 115 61 18
2023/2024612 29 74 88 42 39 57 36 57 27 32 72 59
2024/20252.801 148 142 20 78 107 171 266 215 144 293 994 223
2025/20263.287 550 375 546 633 1.042 141 0 0 0 0 0 0
Totale 9.372